Russell Szmulewitz, MDAssistant Professor of MedicineRussell Szmulewitz, MD, is an expert in the treatment and management of prostate, bladder, kidney, and testicular cancers. His clinical focus is on the treatment of patients with advanced prostate cancer, with particular expertise in the use of leading-edge hormonal, targeted, and immunotherapies. Dr. Szmulewitz works in close collaboration with urologists, radiation oncologists, and geriatricians who also specialize in the care of prostate cancer patients. His research bridges the clinic and laboratory and focuses on the process of prostate cancer metastasis. In particular, his research attempts to better define the steps involved in metastatic progression and evolution to castration resistance in prostate cancer, with the goal of developing targeted therapies for these processes. In addition, Dr. Szmulewitz’s laboratory is developing strategies to isolate and interrogate circulating tumor cells (CTC) to better understand the biology of prostate cancer, and eventually personalize care based on this individualized biology. Dr. Szmulewitz is particularly involved in therapeutic development for prostate cancer. He is an investigator on many clinical research trials focusing on immunotherapy, anti-angiogentic, and other novel targeted therapies for prostate cancer. Practice LocationCenter for Advanced Medicine
Year Started Practice2009 Board CertificationsInternal Medicine
Medical SchoolPritzker School of Medicine, University of Chicago Internship and ResidencyNew York Medical Center FellowshipThe University of Chicago Medicine MembershipsAmerican Association for Cancer Research
Language SpokenEnglish Office Phone(773) 702-7609 Office Fax(773) 702-3163 Office Postal AddressRussell Szmulewitz, MD
|
Clinical Interests
Request an appointment online
Physicians, contact the
Selected PublicationsView a partial list of Dr. Szmulewitz's publications through the National Library of Medicine's PubMed online database. |
